Assessing Whether Xeris Biopharma Holdings Inc (NASDAQ: XERS) Is Over- Or Undervalued
Xeris Biopharma Holdings Inc (XERS) concluded trading on Wednesday at a closing price of $5.71, with 4.63 million shares of worth about $26.44 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 106.88% during that period and on March 26, 2025 the price saw […]
Xeris Biopharma Holdings Inc (NASDAQ: XERS) Hogging The Spotlight Today
Currently, there are 149.43M common shares owned by the public and among those 142.00M shares have been available to trade. The company’s stock has a 5-day price change of 18.91% and 53.53% over the past three months. XERS shares are trading 53.98% year to date (YTD), with the 12-month market performance up to 145.07% higher. […]
Analysts Update Their Price Forecasts For Xeris Biopharma Holdings Inc (XERS)
Xeris Biopharma Holdings Inc (XERS) concluded trading on Thursday at a closing price of $4.13, with 9.56 million shares of worth about $39.48 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 59.46% during that period and on March 06, 2025 the price saw […]
Following The Money: Institution’s Growing Stake In Xeris Biopharma Holdings Inc (NASDAQ: XERS)
Xeris Biopharma Holdings Inc (XERS) concluded trading on Wednesday at a closing price of $3.21, with 4.13 million shares of worth about $13.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 43.95% during that period and on Wednesday the price saw a gain […]
Is Xeris Biopharma Holdings Inc (NASDAQ: XERS) Proving The Doubters Wrong?
BlackRock Fund Advisors has recently announced that it has increased stake in Xeris Biopharma Holdings Inc (NASDAQ:XERS) by 0.67%. After grabbing 8.4 million shares, the institutional investor is now in possession of 56076.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.08% having worth around $15.63 million. Moreover, […]
Is Xeris Biopharma Holdings Inc (NASDAQ: XERS) Proving The Doubters Wrong?
BlackRock Fund Advisors has recently announced that it has increased stake in Xeris Biopharma Holdings Inc (NASDAQ:XERS) by 0.67%. After grabbing 8.4 million shares, the institutional investor is now in possession of 56076.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.08% having worth around $15.63 million. Moreover, […]
